Status:
UNKNOWN
Japanese Upper GI Symptoms Compared With Iranian and Canadian Patients Presenting
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborating Sponsors:
Tohoku University
Tehran University of Medical Sciences
Conditions:
Functional Dyspepsia
Gastro Esophageal Reflux
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this prospective cohort study is to compare upper GI symptoms and endoscopy findings in Canada with Japan and Iran, and correlate this with the upper GI microbiome. The investigators pl...
Detailed Description
Objective The purpose of the trial is to compare upper GI symptoms and endoscopy findings in Canada with Japan and Iran, and correlate this with the upper GI microbiome. The primary outcomes is the b...
Eligibility Criteria
Inclusion
- adult patients (≥18 years of age) who are undergoing esophago-gastro duodenoscopy (EGD) for any reason and are consenting to be enrolled in the study during the study period.
Exclusion
- the patients who cannot speak English in Canada, who cannot speak Japanese in Japan, and cannot speak Persian in Iran.
Key Trial Info
Start Date :
May 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT03868267
Start Date
May 9 2019
End Date
December 1 2023
Last Update
February 9 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton Health Science Centre
Hamilton, Ontario, Canada
2
Digestive Disease Research Institute, Tehran University of Medical Sciences
Tehran, Iran, 14117
3
Tohoku University Hospital
Sendai, Miyagi, Japan, 9808574